STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences
MONROVIA, Calif., May 29, 2012 /PRNewswire/ — STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will participate in two upcoming investor conferences to review the Company’s recent financial results and current business developments with investors and interested parties.
The Benchmark Company One-on-One Investor Conference will be held on Thursday, May 31, 2012 at the Pfister Hotel in Milwaukee, Wisconsin. Barry G. Caldwell, President and CEO, and Deborah Andrews, CFO, will meet with interested investors in a series of one-on-one meetings.
This Benchmark Company Investor Conference does not provide for companies to webcast the event; however, a copy of the Company’s Conference presentation will be available at the Company’s website, www.staar.com, under Investor Information. Investors planning to attend the conference should contact their Benchmark representative to arrange a meeting.
The Company will also present at the Jefferies 2012 Global Healthcare Conference in New York on Thursday, June 7, 2012 at 3:00 p.m. ET. Barry G. Caldwell, President and CEO, Deborah Andrews, CFO, and Sam Gesten, General Counsel, will be attending the conference.
STAAR will offer a live video webcast of its presentation on the Company’s website, www.staar.com, under Investor Information. An archived replay of the presentation will be available for 30 days, also at www.staar.com.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or “ICL.” A lens used to replace the natural lens after cataract surgery is called an intraocular lens or “IOL.” Over 300,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in approximately 50 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company’s website at www.staar.com or call 626-303-7902.
Collamer® is the registered trademark for STAAR’s proprietary biocompatible collagen copolymer lens material.
CONTACT: Investors Media EVC Group EVC Group Douglas Sherk, 415-652-9100 Chris Gale Jenifer Kirtland, 415-568-9349 646-201-5431
SOURCE STAAR Surgical Company